Showing 1001 - 1025 of 1,441
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3) Protocol
Recruiting
- Mild Cognitive Impairment (MCI)
- Alzheimer's Disease (AD)
-
Birmingham, Alabama
- +58 more
Jun 15, 2022
Amblyopia Trial in Dallas (Binocular games for treatment of amblyopia)
Recruiting
- Amblyopia
- Binocular games for treatment of amblyopia
-
Dallas, TexasRetina Foundation of the Southwest
Jun 17, 2022
Hereditary Angioedema Trial in Canada, Puerto Rico, United States (Placebo, KVD900 600 mg, KVD900 300 mg)
Recruiting
- Hereditary Angioedema
- Placebo
- +2 more
-
Birmingham, Alabama
- +14 more
Jun 16, 2022
Abdominal (ABD) Infection Trial in United States (Arm 1: Routine Care, Arm 2: INSPIRE CPOE Smart Prompt for Abdominal Infection)
Not yet recruiting
- Abdominal (ABD) Infection
- Arm 1: Routine Care
- Arm 2: INSPIRE CPOE Smart Prompt for Abdominal Infection
-
Riverside, California
- +100 more
Jun 14, 2022
Skin and Soft Tissue (SST) Infection Trial in United States (Arm 1: Routine Care, Arm 2: INSPIRE CPOE Smart Prompt for Skin and
Not yet recruiting
- Skin and Soft Tissue (SST) Infection
- Arm 1: Routine Care
- Arm 2: INSPIRE CPOE Smart Prompt for Skin and Soft Tissue Infection
-
Riverside, California
- +101 more
Jun 14, 2022
Diabetes Trial in United States (Blood glucose meter, Eversense CGM System)
Recruiting
- Diabetes
- Blood glucose meter
- Eversense CGM System
-
Los Angeles, California
- +15 more
Jun 15, 2022
Kidney Transplantation Trial in United States (TCD601)
Not yet recruiting
- Kidney Transplantation
- TCD601
-
Chicago, Illinois
- +4 more
Jun 13, 2022
Relapsed/Refractory Chronic Lymphocytic Leukemia, Richter's Syndrome Trial in Worldwide (Epcoritamab)
Recruiting
- Relapsed/Refractory Chronic Lymphocytic Leukemia
- Richter's Syndrome
- Epcoritamab
-
Tuscaloosa, Alabama
- +22 more
Jun 15, 2022
Preclinical Alzheimer's Disease, Early Preclinical Alzheimer's Disease Trial in Worldwide (Lecanemab, Placebo)
Recruiting
- Preclinical Alzheimer's Disease
- Early Preclinical Alzheimer's Disease
- Lecanemab
- Placebo
-
Birmingham, Alabama
- +103 more
Jun 14, 2022
Mitral Regurgitation, Mitral Insufficiency, Mitral Valve Insufficiency Trial in Canada, United States (Tendyne Mitral Valve
Recruiting
- Mitral Regurgitation
- +7 more
- Tendyne Mitral Valve System
- MitraClip System
-
Birmingham, Alabama
- +77 more
Jun 13, 2022
Diabetic Foot Ulcers, Osteomyelitis Trial in Dallas (DFU)
Recruiting
- Diabetic Foot Ulcers
- Osteomyelitis
- DFU
-
Dallas, Texas
- +1 more
Jun 14, 2022
Suicide Trial in United States (Coping Long Term with Active Suicide Program (CLASP))
Recruiting
- Suicide
- Coping Long Term with Active Suicide Program (CLASP)
-
Little Rock, Arkansas
- +8 more
Jun 13, 2022
Squamous Cell Carcinoma of the Anal Canal Trial in Worldwide (carboplatin, paclitaxel, retifanlimab)
Recruiting
- Squamous Cell Carcinoma of the Anal Canal
- carboplatin
- +2 more
-
Tucson, Arizona
- +85 more
Jun 13, 2022
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- SRF617
- +2 more
-
Miami, Florida
- +6 more
Jun 13, 2022
CNS B-Cell Non-Hodgkin Lymphoma Trial in United States (procedure, biological, other)
Recruiting
- Central Nervous System B-Cell Non-Hodgkin Lymphoma
- Cognitive Assessment
- +2 more
-
Denver, Colorado
- +11 more
Jun 9, 2022
Diabetes, Type 2 Trial in Worldwide (Metformin DR, Metformin IR, Metformin DR Placebo)
Recruiting
- Diabetes Mellitus, Type 2
- Metformin DR
- +3 more
-
Glendale, Arizona
- +86 more
Jun 7, 2022
Hypertension Trial in United States (Dehydrated alcohol, Peregrine System Kit (Sham Procedure))
Recruiting
- Hypertension
- Dehydrated alcohol
- Peregrine System Kit (Sham Procedure)
-
Birmingham, Alabama
- +4 more
Jun 8, 2022
Cervical Cancer by FIGO Stage 2018 Trial in Birmingham, La Jolla, Dallas (Varian Ethos Adaptive Radiation Therapy)
Recruiting
- Cervical Cancer by FIGO Stage 2018
- Varian Ethos Adaptive Radiation Therapy
-
Birmingham, Alabama
- +2 more
Jun 7, 2022